Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)

China flag China · Delayed Price · Currency is CNY
2.500
+0.040 (1.63%)
Apr 29, 2026, 3:00 PM CST
5.93%
Market Cap 7.96B
Revenue (ttm) 1.75B
Net Income (ttm) -357.09M
Shares Out 3.18B
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 34,416,572
Average Volume 55,228,865
Open 2.460
Previous Close 2.460
Day's Range 2.440 - 2.510
52-Week Range 2.300 - 3.230
Beta 0.22
RSI 47.01
Earnings Date Apr 30, 2026

About SHA:600252

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and othe... [Read more]

Sector Healthcare
Founded 1993
Employees 2,971
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600252
Full Company Profile

Financial Performance

In 2025, SHA:600252's revenue was 1.75 billion, a decrease of -16.92% compared to the previous year's 2.10 billion. Losses were -357.09 million, -5.28% less than in 2024.

Financial Statements

News

There is no news available yet.